-
公开(公告)号:US10568849B1
公开(公告)日:2020-02-25
申请号:US16182906
申请日:2018-11-07
申请人: KING SAUD UNIVERSITY
IPC分类号: A61K36/00 , A61K31/122 , A61P31/04 , A61K47/44 , A61K9/107
摘要: A method for preventing, treating, or ameliorating a microbial infection can include administering thymoquinone or a pharmaceutical composition comprising thymoquinone to a patient in need thereof. The patient may be suffering from a microbial infection caused by gram-negative bacteria, gram-positive bacteria, or fungi. The microbial infection may be caused by gram negative bacteria. The gram-negative bacteria may include Acinetobacter baumannii. The gram-negative bacteria may include Pseudomonas aeruginosa. The microbial infection may be caused by antimicrobial sensitive Acinetobacter baumannii or antimicrobial resistant Acinetobacter baumannii.
-
公开(公告)号:US11617726B2
公开(公告)日:2023-04-04
申请号:US16723773
申请日:2019-12-20
申请人: KING SAUD UNIVERSITY
IPC分类号: A61K36/00 , A61K31/122 , A61P31/04 , A61K47/44 , A61K9/107
摘要: A method for preventing, treating, or ameliorating a microbial infection can include administering thymoquinone or a pharmaceutical composition comprising thymoquinone to a patient in need thereof. The patient may be suffering from a microbial infection caused by gram-negative bacteria, gram-positive bacteria, or fungi. The microbial infection may be caused by gram negative bacteria. The gram-negative bacteria may include Acinetobacter baumannii. The gram-negative bacteria may include Pseudomonas aeruginosa. The microbial infection may be caused by antimicrobial sensitive Acinetobacter baumannii or antimicrobial resistant Acinetobacter baumannii.
-